<DOC>
	<DOC>NCT00141310</DOC>
	<brief_summary>To determine the efficacy and safety of sildenafil citrate in the treatment of established pre-eclampsia</brief_summary>
	<brief_title>Sildenafil Citrate for the Treatment of Established Pre-Eclampsia</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Subjects with preeclampsia defined as new hypertension with a diastolic BP of &gt; or = 90 mmHg on two occasions separated by at least 4 hrs arising after 20 weeks of pregnancy, associated with &gt;500 mg/24 hr proteinuria. Subjects with preexisting hypertension (on treatment) need only fulfill proteinuria requirement. Gestational age 2434 w Singleton pregnancy Where urgent delivery is indicated Where the fetus is suspected to have a structural or chromosomal abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>